We are live on ! Find out more
CNST

Constellation Pharmaceuticals, Inc.
CNST

Delisted

CNST was delisted on the 14th of July, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Constellation Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 153 closing their positions.

New
Increased
Maintained
Reduced
Closed

91.56% less ownership

Funds ownership: 91.56% → 0% (-92%)

100% less funds holding

Funds holding: 153 → 0 (-153)

100% less funds holding in top 10

Funds holding in top 10: 9 → 0 (-9)

100% less capital invested

Capital invested by funds: $1.48B → $0 (-$1.48B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 153

Holders
–
Holders Change
-153
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
153
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$108M
2
BlackRock
BlackRock
New York
-$94M
3
CG
Column Group
California
-$88.8M
4
PM
Ponoi Management
California
-$63.6M
5
MF
Magnetar Financial
Illinois
-$61.8M

CNST Hedge Fund Activity: Q3 2021 in Review

0 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Constellation Pharmaceuticals, Inc. (CNST) for Q3 2021, worth a combined $0 — down 100% from $1.48B a quarter earlier.

Sellers outnumbered buyers: 153 funds closed out of CNST and 0 opened new positions — a net loss of 153 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $108M sold.

  • 0 institutional investors held Constellation Pharmaceuticals, Inc. (CNST) as of Q3 2021, down from 153 in Q2 2021.
  • Funds reported $0 of Constellation Pharmaceuticals, Inc. stock for Q3 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Constellation Pharmaceuticals, Inc. positions in Q3 2021 and 153 closed out, a net change of -153 holders.
  • The largest Constellation Pharmaceuticals, Inc. seller in Q3 2021 was Avoro Capital Advisors, an estimated $108M sold.

Based on aggregated 13F filings for Q3 2021.